I-MOVE-COVID-19 publications

Protocols

Vaccine effectiveness studies

I-MOVE-COVID-19 hospital network VE generic protocol: European study of COVID-19 vaccine effectiveness against hospitalised SARI patients laboratory-confirmed with SARS-CoV-2

I-MOVE-COVID-19 primary care network VE generic protocol: COVID-19 vaccine effectiveness at primary care level in Europe

Risk factor studies

I-MOVE-COVID-19 hospital network risk factor generic protocol: European study of risk factors for severe disease among hospitalised COVID-19 patients

I-MOVE-COVID-19 primary care network risk factor generic protocol: Risk factors for COVID-19 at primary care level in Europe

Surveillance

I-MOVE-COVID-19 hospital surveillance protocol

I-MOVE-COVID-19 primary care surveillance protocol

Scientific articles

Kissling E, Hooiveld M, Sandonis Martín V, Martínez-Baz I, William N, Vilcu AM, Mazagatos C, Domegan L, de Lusignan S, Meijer A, Machado A, Brytting M, Casado I, Murray JK, Belhillil S, Larrauri A, O’Donnell J, Tsang R, de Lange M, Rodrigues AP, Riess M, Castilla J, Hamilton M, Falchi A, Pozo F, Dunford L, Cogdale J, Jansen T, Guiomar R, Enkirch T, Burgui C, Sigerson D, Blanchon T, Martínez Ochoa EM, Connell J, Ellis J, van Gageldonk-Lafeber R, Kislaya I, Rose AM, Valenciano M; I-MOVE-COVID-19 primary care study team; I-MOVE-COVID-19 primary care study team (in addition to authors above). Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021. Euro Surveill. 2021 Jul;26(29):2100670.

Trobajo-Sanmartín C, Adelantado M, Navascués A, Guembe MJ, Rodrigo-Rincón I, Castilla J, Ezpeleta C. Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR. J. Clin. Med. 2021, 10, 299. https://doi.org/10.3390/jcm10020299

Castilla J., Guevara M., Miqueleiz A., Baigorria F., Ibero-Esparza C., Navascués A., Trobajo-Sanmartín C., Martínez-Baz I., Casado I., Burgui C., Ezpeleta C., The Working Group for the Study of COVID-19 in Navarra. Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study. Journal of Clinical Medicine. 2021; 10(12):2608. https://doi.org/10.3390/jcm10122608

Trobajo-Sanmartín C, Navascués A, Miqueleiz A, Ezpeleta C. Evaluation of the rapid antigen test CerTest SARS-CoV-2 as an alternative COVID-19 diagnosis technique. Infect Dis (Lond). 2021 Mar 18:1-3. https://doi.org/10.1080/23744235.2021.1902563.

Martínez-Baz I, Miqueleiz A, Casado I, Navascués A, Trobajo-Sanmartín C, Burgui C, Guevara M, Ezpeleta C, Castilla J, Working Group for the Study of COVID-19 in Navarra. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021. Euro Surveill. 2021;26(21):pii=2100438. https://doi.org/10.2807/1560-7917.ES.2021.26.21.2100438

Trobajo-Sanmartín C, Miqueleiz A, Portillo ME, Fernández-Huerta M, Navascués A, Sola Sara P, Moreno PL, Ordoñez GR, Castilla J, Ezpeleta C. Emergence of SARS-CoV-2 variant B.1.575.2 containing the E484K mutation in the spike protein in Pamplona (Spain) May-June 2021. J Clin Microbiol. 2021 Sep 8:JCM0173621. https://doi.org/10.1128/JCM.01736-21.

Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Guevara M, Fernández-Huerta M, et al.; Investigators, other members of the Working Group for the Study of COVID-19 in Navarre. Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021. Euro Surveill. 2021 Sep;26(39):2100894. https://doi.org/10.2807/1560-7917.ES.2021.26.39.2100894

Trobajo-Sanmartín C, Miqueleiz A, Portillo ME, Fernández-Huerta M, Navascués A, Castilla J, Ezpeleta C. Utility of a commercial RT-qPCR assay to detect SARS-CoV-2 gene variations as an indicator of lineages. J Virol Methods. 2022;300:114428. https://doi.org/10.1016/j.jviromet.2021.114428

Martínez-Baz I, Trobajo-Sanmartín C, Burgui C, Casado I, Castilla J. Transmission of SARS-CoV-2 infection and risk factors in a cohort of close contacts. Postgrad Med. 2022 Feb 7:1-9. doi: 10.1080/00325481.2022.2037360.

Trobajo-Sanmartín C, Martínez-Baz I, Miqueleiz A, Fernández-Huerta M, Casado I, Navascués A, Castilla J, Ezpeleta C. Differences in transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) variants of concern. (article under revision).

Fresán U., Guevara M., Elía F., Albéniz E., Burgui C., Castilla J.; Working Group for the Study of COVID-19 in Navarra. (2020), Independent role of morbid obesity as a risk factor for COVID‐19 hospitalization: a Spanish population‐based cohort study. Obesity. Accepted Author Manuscript. doi:10.1002/oby.23029

Martínez-Baz, I., Trobajo-Sanmartín, C., Arregui, I., Navascués, A., Adelantado, M., Indurain, J., Fresán, U., Ezpeleta, C., & Castilla, J. (2020). Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers. Vaccines, 8(4), 611. https://doi.org/10.3390/vaccines8040611

Fresán U., Guevara M., Trobajo-Sanmartin C., Burgui C., Ezpeleta C., Castilla J. (2021), Hypertension and related comorbidities as potential risk factors for COVID‐19 hospitalization and severity: a prospective population‐based cohort study. J Clin Med 2021 10(6); 1194. doi: 10.3390/jcm.10061194.

Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez-Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A, Castilla J, William N, Carnahan A, Falchi A, Hendriksen J, Casado I, Murray J, Enouf V, Dijkstra F, Marques DFP, Valenciano M. Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020. Influenza Other Respir Viruses. 2021 Jan 22:10.1111/irv.12839. doi: 10.1111/irv.12839.

Surveillance reports

Hospital based reports

WP3 hospital surveillance bulletin September 2020

WP3 hospital surveillance bulletin December 2020 (revised Jan 2021)

WP3 hospital surveillance bulletin March 2021

WP3 hospital surveillance bulletin June 2021

WP3 hospital surveillance bulletin September 2021

WP3 hospital surveillance final bulletin March 2022

WP3 hospital surveillance monitoring and evaluation report March 2022

Primary care based reports

WP2 primary care surveillance bulletin September 2020

WP2 primary care surveillance bulletin March 2021

WP2 primary care surveillance bulletin July 2021

WP2 primary care surveillance bulletin December 2021

Tools

Sample size calculator for evaluation of COVID-19 vaccine effectiveness using the test-negative design (Excel spreadsheet)

Presentation on integrating genetic sequencing information into vaccine effectiveness analyses (the experience from I-MOVE influenza)

Data collection tool for linking epidemiological and sequencing data, including sampling fraction (Excel spreadsheet)

Scientific presentations and posters

Rose A, Lovric Makaric Z, Mazagatos C, Launay O, Denayer S, et al. 2021 COVID-19 vaccine effectiveness against hospitalisation due to laboratory-confirmed SARS-CoV-2 infection in older adults: pooled results from eight European countries. ESCAIDE, 16–19 November 2021.

Kissling E, Hooiveld M., Brytting M., Vilcu AM, de Lange M., et al. Absence of association between 2019-20 influenza vaccination and COVID-19: results of the I-MOVE-COVID-19 primary care project, March-August 2020. ESWI, 6-9 December 2020.

Mokogwu D, Hamilton M, Harvey C, Elgohari S, Burgui C, Mazagatos C, Galtier F, Vasili A, Seyler L, Machado A, Jonikaite I, Lazar M, Rath B, Mutch H, McMahon J, Ladbury G, Akinnawo A, Martínez-Baz I, Larrauri A, Laine F, Fico A, Demuyser T, Kislaya I, Gefenaite G, Cherciu C, Harrabi M, Rose AMC, I-MOVE study group. Enhanced surveillance of COVID-19 in secondary care in Europe: a tale of two waves. ESCAIDE, 16-19 November 2021.

Ladbury G, Hamilton M, Harvey C, Mutch H, McMahon J, Mokogwu D, Sadiq F, Young J, Wallace L, Murray J, Lopez‑Bernal J, Andrews N, Castilla J, Casado I, Larrauri A, Mazagatos C, Duval X, Bino S, Demuyser T, Machado A, Mickiene A, Lazar M, Rath B, Harrabi M, Rekacewicz C, Kapisyszi P, Seyler L, Gomez V, Jancoriene L, Rose AMC, I-MOVE study group. Establishing a novel European hospital surveillance platform in response to a newly emerging infection: lessons from the I-MOVE-COVID-19 hospital network. ESCAIDE, 16-19 November 2021.